FOXO3a and ID1 as targets of chemotherapy in breast cancer
Cancer is one of the leading causes of death and more than 40000 women are diagnosed every year in the UK with breast cancer. Chemotherapy regimens containing the anthracycline epirubicin are often used in the medical management of breast cancer, but the cellular mechanisms of action and the molecul...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2009
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.516750 |